BioSpace News Archive

Business

Portage Announces Change of CEO

The Board of Directors of Portage Biotech Inc announces that Dr. Declan Doogan, the current Chief Executive Officer (“CEO”) has decided to step down with immediate effect.

May 6, 2019
·
5 min read
Pharm Country

Expanded role for Cysview® (hexaminolevulinate HCl) in treating bladder cancer patients -- presented at the 2019 AUA Annual Meeting

Photocure ASA announced key data presented at the 2019 American Urological Association Annual Meeting in Chicago.

May 6, 2019
·
5 min read
Job Trends

Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2019

Clovis Oncology, Inc. announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the Bank of America Merrill Lynch Healthcare Conference 2019 on Tuesday, May 14, 2019 at 2:20 PM Pacific Time.

May 6, 2019
·
1 min read
Genetown

Moderna to Present at Bank of America Merrill Lynch 2019 Health Care Conference

Moderna, Inc. announced that Tal Zaks, M.D., Ph.D., Chief Medical Officer, and Lorence Kim, M.D., Chief Financial Officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019 at 9:20 a.m. PT.

May 6, 2019
·
2 min read
Selexis to Present Data at ESACT 2019 from the SUREtechnology and Beacon® Optofluidic Collaboration

Research Cell Banks Produce Therapeutic Proteins in Just Eight Weeks as Validated in Oral Presentation on Integration of Berkeley Lights’ Beacon Optofluidic Platform with Selexis’ Workflow and Clone Prediction Tool

May 6, 2019
·
5 min read
Biotech Beach

Progenity to Showcase New Data at Digestive Disease Week®

Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, this week announced three upcoming poster presentations.

May 6, 2019
·
3 min read
Business

New Metabolic Biomarkers Open Door to Earlier Diagnosis, More Precise and Individualized Treatment of Children at Risk for Autism

Continued analysis of samples from the Children’s Autism Metabolome Project (CAMP), the most comprehensive clinical study of metabolism in children who have autism spectrum disorder (ASD) conducted to date, has identified three new areas of metabolism that affect the biology of children with ASD

May 6, 2019
·
4 min read
Drug Development

Urovant Sciences Presents Positive Pivotal Data for Vibegron During Plenary Session at American Urological Association Annual Meeting

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced Dr. David Staskin presented positive, Phase 3 pivotal data demonstrating safety and efficacy of vibegron during a plenary session at the 2019 American Urological Association Annual Meeting (AUA) in Chicago yesterday afternoon.

May 6, 2019
·
6 min read
Drug Development

Xencor Doses First Patient in Phase 1 Study of XmAb®23104 for the Treatment of Patients with Advanced Solid Tumors

XmAb23104, a PD-1 x ICOS bispecific antibody, is the sixth XmAb® antibody engineered with Xencor’s bispecific Fc domain to enter clinical development

May 6, 2019
·
4 min read
Business

Ballad Health and Premier Inc. Partner on Enterprise-wide Performance Improvement Initiative

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has expanded its partnership with Ballad Health, an integrated health system that serves 29 counties across four Southeastern states

May 6, 2019
·
5 min read